From virtual to real screening for D3 dopamine receptor ligands

被引:21
作者
Byvatov, E
Sasse, BC
Stark, H
Schneider, G
机构
[1] Univ Frankfurt, Inst Organ Chem & Chem Biol, Fachbereich Chem & Pharm Wissensch, Beilstein Endowed Chair Cheminformat, D-60439 Frankfurt, Germany
[2] Univ Frankfurt, Inst Pharmaceut Chem, D-60439 Frankfurt, Germany
关键词
bioinformatics; drug discovery; G protein-coupled receptors; pharmacophores; screening; similarity;
D O I
10.1002/cbic.200400400
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Even in the absence of receptor-structure information, iterative virtual screening cycles with support vector machines (SVM) offer a rapid way to identify novel leads with minimal experimental effort. First, an SVM is trained for prediction of D3 receptor-selective ligands. Based on the prediction of this virtual filter, compounds are tested for binding affinity at D2 and D3 receptors. Second, a similarity search is performed with the most promising candidate from round one. Four out of five compounds from the final hit list exhibited nanomolar affinity at the D 3 receptor including a novel scaffold structure. The Ki value of the best molecule (1) was 40±6 nM. © 2005 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:997 / 999
页数:3
相关论文
共 19 条
[1]  
[Anonymous], MOE MOL OP ENV VERS
[2]   CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA [J].
BUNZOW, JR ;
VANTOL, HHM ;
GRANDY, DK ;
ALBERT, P ;
SALON, J ;
CHRISTIE, MJ ;
MACHIDA, CA ;
NEVE, KA ;
CIVELLI, O .
NATURE, 1988, 336 (6201) :783-787
[3]   SVM-based feature selection for characterization of focused compound collections [J].
Byvatov, E ;
Schneider, G .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (03) :993-999
[4]   Comparison of support vector machine and artificial neural network systems for drug/nondrug classification [J].
Byvatov, E ;
Fechner, U ;
Sadowski, J ;
Schneider, G .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2003, 43 (06) :1882-1889
[5]  
Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67
[6]   N-(ω-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands [J].
Hackling, A ;
Ghosh, R ;
Perachon, S ;
Mann, A ;
Höltje, HD ;
Wermuth, CG ;
Schwartz, JC ;
Sippl, W ;
Sokoloff, P ;
Stark, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (18) :3883-3899
[7]  
Hackling AE, 2002, CHEMBIOCHEM, V3, P946, DOI 10.1002/1439-7633(20021004)3:10<946::AID-CBIC946>3.0.CO
[8]  
2-5
[9]  
Joachims T., 1999, ADV KERNEL METHODS S
[10]   Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs [J].
Joyce, JN .
PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :231-259